Company

Abridge

AI platform for doctors that transcribes and summarizes patient conversations, enabling physicians to focus on care rather than documentation. Founded in 2018.

Healthcare & Biotech

Funding History

Jun 3, 2025

Abridge raised a round led by Andreessen Horowitz and Coastal Ventures at a $5.3B valuation, doubling its valuation from earlier in 2025. Earlier backers include IVP, Elad Gil, Spark Capital, Bessemer, and Union Square Ventures.

Investors

Andreessen HorowitzSpark Capital

News

News (1)

Abridge raises at $5.3B valuation as AI for doctors doubles in value within months
2 Jun 2025